Lourd Capital’s Medtronic MDT Stock Holding History

Lourd Capital’s Portfolio MDT Stock Details MDT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-4,100	Closed	-$320K	–	122
2015 Q1	$320K	Buy	4,100 +212	+5%	+$16.1K	0.03%	90
2014 Q4	$281K	Sell	3,888 -44	-1%	-$3.06K	0.03%	95
2014 Q3	$244K	Buy	+3,932	New	+$250K	0.02%	103
2013 Q3	–	Sell	-10,000	Closed	-$515K	–	111
2013 Q2	$515K	Buy	+10,000	New	+$494K	0.06%	52

Other funds holding MDT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Lourd Capital's MDT Position: Q2 2015 in Review

Lourd Capital sold out of Medtronic (MDT) in Q2 2015, closing a stake of 4,100 shares — an estimated $320K sold.

Lourd Capital first reported a position in MDT in Q2 2013 and held it in 4 quarters. The position peaked at $515K in Q2 2013. 1,259 funds tracked by Wall St. Rank hold MDT as of Q2 2015.

Lourd Capital reported no remaining Medtronic position as of Q2 2015 after selling out during the quarter.
Lourd Capital sold 4,100 Medtronic shares in Q2 2015, an estimated $320K.
Lourd Capital first reported a position in Medtronic in Q2 2013 and held it in 4 quarters.
Lourd Capital's Medtronic position peaked at $515K in Q2 2013.
1,259 funds tracked by Wall St. Rank held Medtronic as of Q2 2015.

Based on Lourd Capital's 13F filing for Q2 2015, filed 30 Jul 2015.